跳至主要內容

註冊委員會從2015年發出有關標籤的信件(按日期索引) (只提供英文版本)

主頁> 指南和表格 > 註冊委員會從2015年發出有關標籤的信件(按日期索引) (只提供英文版本)

註冊委員會從2015年發出有關標籤的信件(按日期索引) (只提供英文版本)

日期	標題
2025-10-23	New Warnings for Isoxazoline
2025-10-23	New Warnings for Third Generation Aromatase Inhibitors
2025-10-23	New Warnings for Valproate Medicines
2025-06-25	New Warnings for Topical Testosterone

日期	標題
2024-12-18	New Warnings for Vitamin B6
2024-11-06	New Warnings for Isotretinoin
2024-11-06	New Warnings for Pseudoephedrine
2024-09-09	New Warnings for Metformin
2024-07-09	New Warnings for Ophthalmic Preparation containing Atropine
2024-06-28	Strengthening the Sales Control of Oral Contraceptives that are currently not regulated as Poisons
2024-04-29	New Warnings for Methylphenidate Long-Acting (modified-release) Preparations
2024-02-28	New Warnings for Statins

日期	標題
No News

日期	標題
2022-05-05	New Warnings for Diuretics
2022-03-01	New Warnings for Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Vortioxetine
2022-03-01	New Warnings for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

日期	標題
2021-12-24	New Warnings for Tramadol
2021-12-24	New Warnings for Hormone Replacement Therapy (HRT)
2021-06-28	New Warnings for Vascular Endothelial Growth Factor (VEGF) Pathway Inhibitors
2021-06-28	New Warnings for Fluorouracil, Capecitabine, Tegafur and Flucytosine
2021-04-19	New Warnings for Products containing Montelukast

日期	標題
2020-12-15	New Warnings for Products containing Cyproterone
2020-12-15	New Warnings for Hydrochlorothiazide Products
2020-06-23	New Warnings for Domperidone Products
2020-06-23	New Warnings for Pregabalin Products

日期	標題
2019-12-06	New Warnings for Lovastatin Products
2019-06-21	Risk Minimisation Measures on Use for Valproate Medicines in Relation to the High Teratogenic Potential and Developmental Disorders in Women of Childbearing Potential
2019-06-21	New Warnings for Sodium／Glucose Co-transporter 2 (SGLT2) Inhibitors
2019-06-21	New Warnings for Fluoroquinolones for Systemic Use
2019-02-22	New Warnings for Topical Oral Benzocaine Products

日期	標題
2018-12-27	New Warnings for Valproate Medicines
2018-06-14	New Warnings for Gadolinium-Based Contrast Agents (GBCAs)

日期	標題
2017-12-12	New Warnings for Isotretinoin
2017-12-12	New Warnings for Gabapentin
2017-12-12	New Warnings for Codeine, Dihydrocodeine and Tramadol
2017-12-12	New Warnings for Chlorhexidine
2017-09-13	New Warnings for Finasteride
2017-05-05	New Warnings for Fluoroquinolones for Systemic Use
2017-02-24	New Warnings for Levonorgestrel-containing Hormonal Contraception
2017-02-24	New Recommendations for Metformin

日期	標題
2016-12-15	New Safety Warnings for Azithromycin
2016-12-15	New Safety Information for Clozapine
2016-09-09	New Safety Warnings for Olanzapine
2016-04-21	New Safety Warnings for Iodine-containing Contrast Agents
2016-04-21	New Safety Warnings for Bisphosphonates
2016-04-21	New Safety Warnings for Potential Interaction between Allopurinol and 6-Mercaptopurine/Azathioprine
2016-02-25	New Safety Warnings for Combined Use of Medicines affecting the Renin-Angiotensin System
2016-02-25	New Safety Warnings for Proton Pump Inhibitors
2016-02-25	New Safety Warnings for Denosumab and Intravenous Bisphosphonates

日期	標題
2015-12-17	New Safety Warnings for Clopidogrel and Repaglinide
2015-10-05	New Safety warnings for Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) excluding Aspirin and Ibuprofen for Systemic Use
2015-05-05	Registered Pharmaceutical Products containing Ambroxol or Bromhexine
2015-02-26	Registered Pharmaceutical Products containing Methyl Salicylate for Topical Administration